Donald Trump has been elected 47th president of the US after the 5 November election having won more than the 270-seat threshold needed. Despite his victory, what a second Trump presidency will mean for the healthcare industry remains unclear.
During his campaign, the Republican spoke little about healthcare policy but did make some declarations, including that he would let Robert F Kennedy Jr “go wild” on healthcare and that RFK Jr would be able to “do what he wants” with women’s healthcare.
Despite Trump’s reluctance to declare an official cabinet role for his one-time third-party rival, RFK Jr said that Trump had “promised” him control over public health agencies, including the Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA).
RFK Jr has already questioned the Prescription Drug User Fee Act in a Washington Post op-ed and is known to be an anti-vaccine activist. It is unclear at this stage quite how much control RFK Jr will have in healthcare.
Before the election, it was predicted that Trump would look to take a second pass at policies which were introduced but did not come to fruition during his first term. One of these is international reference pricing, more commonly known as the Most Favored Nation (MFN) rule. Trump’s 2020 version stated it would establish a mandatory seven-year demonstration to tie prices for drugs under Medicare Part B to the lower prices given to other countries.
During his campaign, Trump said he intends to repeal Biden’s Artificial Intelligence Executive Order (EO), which he states “hinders innovation” and looks to support AI development “rooted in free speech and human flourishing”. The 2019 Trump EO, which is expected to be a springboard, focused on R&D in the AI field.
Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
View profiles in store
Company Profile – free
sample
Your download email will arrive shortly
We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form
By GlobalData
Country *
UK
USA
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint
Eustatius
and
Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean
Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo
Democratic Republic
of
the Congo
Cook Islands
Costa Rica
Côte d”Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern
Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and
McDonald
Islands
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kuwait
Kyrgyzstan
Lao
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia,
The
Former
Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint
Helena,
Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Pierre and Miquelon
Saint Vincent and
The
Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South
Georgia
and The South
Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
US Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
British Virgin Islands
US Virgin Islands
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Kosovo
Industry *
Academia & Education
Aerospace, Defense &
Security
Agriculture
Asset Management
Automotive
Banking & Payments
Chemicals
Construction
Consumer
Foodservice
Government, trade bodies
and NGOs
Health & Fitness
Hospitals & Healthcare
HR, Staffing &
Recruitment
Insurance
Investment Banking
Legal Services
Management Consulting
Marketing & Advertising
Media & Publishing
Medical Devices
Mining
Oil & Gas
Packaging
Pharmaceuticals
Power & Utilities
Private Equity
Real Estate
Retail
Sport
Technology
Telecom
Transportation &
Logistics
Travel, Tourism &
Hospitality
Venture Capital
Tick here to opt out of curated industry news, reports, and event updates from Clinical Trials Arena.
Submit and
download
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
In his first term, Trump was unable to overturn Obamacare, also known as the Affordable Care Act. He has said he would be looking to put in a new system, calling the act “lousy healthcare”. When asked in the ABC News debate in September what his plan would be, Trump said he had “concepts of a plan” to replace the ACA but provided no details.
Trump attempted to partially repeal the ACA by passing the American Health Care Act (ACHA), which would have repealed the individual and employer mandate, amended Medicaid eligibility, and weakened protections for patients with pre-existing conditions.
A new chair of the US Federal Trade Commission (FTC) will be assigned under the Trump administration, despite Trump’s vice-presidential candidate JD Vance complimenting the current Democratic chair Lina Khan on her tenure, including praising her work challenging certain FDA orange book patents.
A central part of Harris’ campaign for abortion rights, however, this may not have had the impact she may have hoped as the 5 November ballot included abortion rights voted for ten states. Despite being a Republican-leaning state, Montana voted to retain the right to abortion. Although Floridians voted to protect abortion rights, due to the ballot needing a super majority, the swing was not enough.
It has already been declared that the Republicans have gained control of the Senate after taking more than the 50-seat threshold needed, with more seats still to be counted.
